- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Regency outlines 3.25%-3.75% same-property NOI growth target while advancing $1B development pipeline | ||
| Fr | U.S. drilling rig count keeps climbing in Baker Hughes survey | ||
| Fr | The Coca-Cola Company climbs for the seventh straight session | ||
| Fr | Plains All American outlines $2.75B EBITDA guidance for 2026 as company executes NGL divestiture, streamlining, and Cactus III integration | ||
| Fr | Dow smashes 50,000 and here's how all 30 stocks rank according to SA Quant Ratings | ||
| Fr | Roivant signals multiple pivotal trial readouts and accelerates brepocitinib Phase III launch in 2026 | ||
| Fr | MarketAxess outlines 8%-9% revenue growth target through 2028 as block trading surges | ||
| Fr | AptarGroup outlines 2026 margin improvement and targets 7%-11% long-term pharma core sales growth amid emergency medicine headwinds | ||
| Fr | Williams weighs buying gas-producing assets to enhance AI energy supply to hyperscalers - Reuters | ||
| Fr | GSK shares uptick for seven consecutive sessions | ||
| Fr | Novartis breaks ground on new R&D center in San Diego | ||
| Fr | Dow tops 50,000 for the first time as the blue-chip rally accelerates | ||
| Fr | Apple plans to update CarPlay to work with third-party AI chatbots: report | ||
| Fr | U.S. consumer credit jumps more than expected in December | ||
| Fr | Catalyst Watch: Crypto swings, FedEx investor event, and Super Bowl bets | ||
| Fr | Tapestry sets record high as Coach delivers --- but can it last? | ||
| Fr | Cboe targets mid- to high single-digit Data Vantage growth and launches event prediction markets amid leadership changes | ||
| Fr | Under Armour outlines $110M operating income target for FY26 as turnaround gains traction | ||
| Fr | Unum projects 8%-12% EPS growth for 2026 as it redefines core metrics and focuses on digital-driven premium expansion | ||
| Fr | Linde downgraded at J.P. Morgan on flat organic growth, weak pricing | ||
| Fr | Envista outlines 2026 guidance with 2%-4% core growth and $1.35-$1.45 adjusted EPS targets amid strong operational momentum | ||
| Fr | Biogen outlines $15.25-$16.25 EPS guidance for 2026 while advancing growth products and pipeline | ||
| Fr | Ameren raises quarterly dividend by 5.6% to $0.75/share | ||
| Fr | SpyGlass Pharma surges on public debut; AgomAb falls | ||
| Fr | Flowserve targets 13% EPS growth for 2026 as nuclear and power end markets accelerate |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.